臺灣癌症用藥事前審查實作指引
1.0.0 - release
臺灣癌症用藥事前審查實作指引
1.0.0 - release
This page is part of the 臺灣健保癌症用藥事前審查實作指引(TWPAS IG) (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 1.2.1. For a full list of available versions, see the Directory of published versions
| Official URL: https://nhicore.nhi.gov.tw/pas/ValueSet/dna-change-type | Version: 1.0.0 | |||
| Active as of 2024-10-09 | Computable Name: DNAChangeType | |||
LOINC-基因突變類型值集
References
Generated Narrative: ValueSet
Expansion based on Loinc v2.78
This value set contains 6 concepts
| Code | System | Display |
| LA6692-3 | http://loinc.org | Deletion |
| LA6686-5 | http://loinc.org | Duplication |
| LA6687-3 | http://loinc.org | Insertion |
| LA6688-1 | http://loinc.org | Insertion/Deletion |
| LA6689-9 | http://loinc.org | Inversion |
| LA6690-7 | http://loinc.org | Substitution |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |